Sort
3,198 grants matching “mrna vaccine”
SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens
$5,902,563Wilton B Williams · Duke University · UM1 · FY2023 · AI
SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens
$5,733,658Wilton B Williams · Duke University · UM1 · FY2024 · AI
SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens
$5,719,876Wilton B Williams · Duke University · UM1 · FY2022 · AI
Core C: Vaccine production and process development
$5,637,003Lauren Carter · University Of Washington · U19 · FY2024 · AI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission
$5,627,958Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Project 2: Current Good Manufacture Practices (CGMP) Production of Nucleoside-Modified mRNAs Encoding HIV-1 Envelopes
$5,274,388Frederick Porter · Duke University · U19 · FY2022 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit - KidCOVE
$5,245,366Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2021 · AI
Design and development of generalizable countermeasures against prototype Phenuiviruses
$5,220,489Amy L Hartman · Washington University · U19 · FY2024 · AI
Development of Nipah virus mRNA vaccine
$5,117,389Rosemarie Mason · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Development and Production of SARS-CoV2 Biologicals and Vaccines
$5,062,451Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2023 · AI
Center for Human Immunology
$5,049,028Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
Prototype strategies for antibodies and vaccines for respiroviruses
$5,035,895Anne Moscona · Washington University · U19 · FY2024 · AI
Project 2 - GMP Manufacturing of mRNA Immunogens
$5,033,198Thomas N Denny · Duke University · U19 · FY2024 · AI
Duke Clinical Good Manufacturing Practices Facility for HIV/AIDS Vaccine Production
$4,900,000Barton F Haynes · Duke University · C06 · FY2017 · OD
Strategically Engineered Multi-Antigen KSHV Vaccine: Integrating Humoral and Cellular Immunity for Effective Protection
$4,857,475Ting-Ting Wu · University Of California Los Angeles · U01 · FY2025 · CA
Exploring novel nucleic acid therapeutic delivery methods and therapeutic strategies
$4,810,759Peter Sarnow · Stanford University · U19 · FY2022 · AI
Project 2: Vaccine Design Epidemic Flaviviruses
$4,782,234Aravinda M De Silva · Washington University · U19 · FY2024 · AI
Project 1: Vaccine Design Neurotropic Flaviviruses
$4,728,047Aaron Gregory Schmidt · Washington University · U19 · FY2024 · AI
SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens
$4,630,856Wilton B Williams · Duke University · UM1 · FY2025 · AI
Project 3: Vaccine Design [mRNA] VEEV/CHIKV (alphaviruses)
$4,622,541Jonathan R. Lai · Washington University · U19 · FY2024 · AI
PanCorVac (Center for Pan-Coronavirus Vaccine Development)
$4,618,169Yoshihiro Kawaoka · University Of Wisconsin-Madison · P01 · FY2023 · AI
Messenger RNA immunogens for initiation of HIV V3-glycan neutralizing B cell lineages
$4,527,376Barton F Haynes · Duke University · U19 · FY2020 · AI
Core 3: Non-human Primate Core
$4,487,359Barton F Haynes · Duke University · P01 · FY2021 · AI
Development and Production of SARS-CoV2 Biologicals and Vaccines
$4,391,926Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2022 · AI
Biodefense and Emerging Infectious Disease and Influenza Vaccine Studies
$4,323,375Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI